Epidermal Langerhans Cells Efficiently Mediate CD1a-Dependent Presentation of Microbial Lipid Antigens to T Cells  by Peña-Cruz, Victor et al.
ORIGINAL ARTICLE
See related Commentary on page vi
Epidermal Langerhans Cells E⁄ciently Mediate CD1a-Dependent
Presentation of Microbial Lipid Antigens to T Cells
Victor Pen a-Cruz, Susumu Ito,
 Christopher C. Dascher,w Michael B. Brenner,w and Masahiko Sugitaz
Department of Immunology and Infectious Disease, Harvard School of Public Health, Boston, Massachusetts, Department of Neurobiology, Harvard
Medical School, Boston, Massachusetts, wDivision of Rheumatology, Immunology, and Allergy, Brigham andWomen’s Hospital and Harvard Medical
School, Boston, Massachusetts, and zDepartment of Microbiology and Immunology, Nippon Medical School,Tokyo, Japan
Langerhans cells are a critical component of skin im-
munity, capable of capturing protein antigens in the
epidermis and presenting them to speci¢c Tcells in the
context of major histocompatibility complex class II
molecules. Recently, a major histocompatibility com-
plex independent pathway of lipid antigen presentation
has been identi¢ed and is mediated by molecules of the
CD1 family (CD1a, CD1b, CD1c, and CD1d). Because
Langerhans cells are professional antigen-presenting
cells and express CD1a molecules prominently, we hy-
pothesized that Langerhans cells might play a role in T
cell responses directed against not only peptide antigens
but also lipid antigens. Here, we show that freshly
isolated immature Langerhans cells as well as mature
Langerhans cells that have migrated from the epidermis
are e⁄cient in presenting foreign microbial lipid anti-
gens to speci¢c T cells whereas dermal dendritic cells
express much less CD1a molecules and function ine⁄-
ciently. Further, we found that Langerhans cells migrating
from epidermal sheets that were exposed to microbial
lipid antigens expressed lipid-antigen-loaded CD1a
molecules on the cell surface, resulting in activation of
speci¢c T cells. These results underscore an outstanding
ability of Langerhans cells to mediate CD1a-dependent
lipid antigen presentation. Thus, Langerhans-cell-
mediated skin immunity may involveTcell recognition
of both peptide and lipid antigens. Key words: CD1a/
Langerhans cells. J Invest Dermatol 121:517 ^521, 2003
L
angerhans cells (LC) are immature dendritic cells (DC)
that localize to the epidermis and play a pivotal role in
initiating antigen-speci¢c T cell responses in the skin
(Banchereau and Steinman, 1998). Following capture
of protein antigens in the epidermis, LC tra⁄c from
the epidermis to regional lymph nodes while di¡erentiating into
mature DC that upregulate surface expression of peptide-loaded
major histocompatibility complex (MHC) encoded class II mole-
cules as well as costimulatory molecules and adhesion molecules
(Teunissen, 1992). Thus, LC e⁄ciently stimulate peptide-antigen-
speci¢c, MHC class II restricted na|«ve T cells to expand, and skin
T cell responses to speci¢c protein antigens are initiated (Moll
et al, 1993; Banchereau and Steinman, 1998).
Besides MHC molecules, human DC express the CD1 family
of non-MHC encoded glycoproteins that are capable of binding
nonprotein lipid antigens and presenting them to T cells (Beck-
man et al, 1994). Group 1 CD1 molecules (CD1a, CD1b, and
CD1c) present microbe-derived lipid and glycolipid antigens to
cytotoxic T cells that may function to clear microbial infection
(Stenger et al, 1997; Rosat et al, 1999), whereas group 2 CD1 mo-
lecules (CD1d) bind a glycolipid, a-galactosylceramide, derived
from marine sponges and activate natural killer T cells that are
proposed to modulate Th1/Th2 balance and control immunity
against various types of infections and tumors (Cui et al, 1997).
Thus, MHC and CD1 molecules appear to mediate distinct, but
complementary, pathways for host defense (Sugita and Brenner,
2000; Gumperz and Brenner, 2001; Dascher and Brenner, 2003).
Among these CD1 isoforms, CD1a molecules are prominently
expressed in epidermal LC as well as DC in epithelia of certain
tissues, such as the bronchus, the gingiva, the conjunctiva, the va-
gina, and the cervix (Crawford et al, 1989; Caux et al, 1992; Miller
et al, 1992; Tazi et al, 1993; Yoshida et al, 1997). This tissue distribu-
tion suggests that CD1a molecules may play a role in antigen pre-
sentation at sites constantly exposed to external pathogens.
Unlike cytokine-induced, monocyte-derived DC that promi-
nently express CD1a, CD1b, and CD1c molecules, epidermal LC
express extremely high levels of CD1a molecules with virtually
no CD1b and only moderate levels of CD1c molecules on the cell
surface (Nestle et al, 1993). Previously, it has been shown that LC
can stimulate CD1a-restricted autoreactive T cells, but the ability
of LC to present foreign lipid antigens remains elusive (Salamero
et al, 2001). Given that LC are professional antigen-presenting cells
that are critical in skin immunity, we hypothesized that LC
might have evolved an outstanding ability to mediate CD1a-de-
pendent presentation of microbe-derived lipid antigens toT cells.
In this study, we isolated epidermal LC and dermal DC from
human skin, and evaluated their ability to present microbe-de-
rived lipid antigens to speci¢c T cells. We show that epidermal
LC are e⁄cient in CD1a-restricted lipid antigen presentation.
MATERIALS ANDMETHODS
Isolation of epidermis-resident LC, LC migrating from the
epidermis, and dermal DC from human skin Normal human skin
was obtained as discarded material from reduction mammoplasty after
approval of the Human Research Committee of the Brigham and
Women’s Hospital, Boston, Massachusetts. Epidermal LC were isolated
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from human skin as described previously (Pen a-Cruz et al, 2001). Brie£y,
following removal of the attached adipose tissue, the skin was digested
with dispase and the epidermis was separated mechanically from the
underlying dermis. The epidermal cells were obtained in single cell
suspension by trypsinizing the epidermis, and were fractionated by
centrifugation in a 15 ml conical tube containing ¢ve layers of the
discontinuous density gradient (from top to bottom: 1.057 g per ml, 1.068
g per ml, 1.079 g per ml, 1.090 g per ml, and 1.100 g per ml). Cells in the
second fraction from the top contained 80% to 490% CD1aþ , E-
cadherinþ cells that expressed Birbeck granules, and the Lag protein
(Pen a-Cruz et al, 2001).
To isolate dermal DC, dermal sheets obtained after removal of the
epidermis were cultured at 371C in RPMI 1640 medium supplemented
with 10% fetal bovine serum in a 10 cm tissue culture dish. After 2 d, the
cells that had migrated from the dermis were harvested and fractionated
using the discontinuous density gradient as described above. The cells in
the second fraction from the top contained 490% MHC class IIþ cells.
Similarly, to isolate LC migrating from the epidermis, the epidermal
sheets were cultured for 2 d and the migrating cells were harvested. The
cells were then fractionated by centrifugation with the discontinuous
density gradient, and the cells from the second fraction from the top were
collected. The identity and purity of the cells are demonstrated in Results.
Tcell stimulation assay To analyze LC and dermal DC for their ability
to mediate CD1a-dependent presentation of microbial lipid antigens to
speci¢c T cells, the T cell receptor derived from the CD8-2 mycobacterial
lipid-antigen-speci¢c CD1a-restricted T cell line was reconstituted in T cell
receptor (TCR) de¢cient J.RT3 cells (CD8-2/J.RT3) (Sugita et al, 1999).
Reconstitution of the speci¢c TCR is su⁄cient to transfer both lipid
antigen speci¢city and CD1a restriction, and thus the CD8-2/J.RT3 cells
are useful to detect CD1a-restricted lipid antigen presentation. The
organic extract of mycobacteria that contained speci¢c antigen recognized
by CD8-2 was obtained as described previously (Rosat et al, 1999). Brie£y,
Mycobacterium tuberculosis (strain H37Ra) was sonicated in phosphate-
bu¡ered saline and extracted with chloroform:methanol in a 2:1 ratio.
Subsequently, the organic phase was recovered and used as antigen in T
cell stimulation assays. In T cell stimulation assays, the TCR-reconstituted
CD8-2/J.RT3 cells (5104 per well) were incubated for 1 d in 96-well,
£at-bottomed microtiter plates with irradiated antigen-presenting cells
(1104 per well) in the presence or absence of the H37Ra organic extract.
To examine whether the antigen-speci¢c response was restricted to CD1a,
some cultures were performed in the presence of nonbinding negative
control antibodies (P3; American Type Culture Collection, Rockville,
MD) or antibodies to either CD1a (10H3, a gift of Drs D. Olive and C.
Mawas) (Olive et al, 1984) or MHC class I molecules (W6/32; American
Type Culture Collection) at the saturating concentration of 10 mg per ml.
To assess T cell activation, the amount of interleukin-2 (IL-2) released into
the supernatants was measured as described previously (Sugita et al, 1999),
using the HT-2 indicator cells, whose proliferation is dependent on IL-2.
Brie£y, aliquots of the culture supernatants were collected after 20 h and
transferred to 96-well microtiter plates containing HT-2 cells (5103 per
well).The HT-2 cells were cultured for 24 h, and [3H]thymidine was added
during the ¢nal 6 h. [3H]Thymidine incorporation was measured with a
liquid scintillation counter.
Electron microscopy To detect Birbeck granules in isolated LC, the
cells were ¢xed at room temperature in 0.1 M cacodylate bu¡er (pH 7.4)
containing 2.5% formaldehyde, 5% glutaraldehyde, and 0.06% picric acid
(Aldrich, Milwaukee, MI). Fixed cells were then embedded in Epon
araldite and 2.4 volumes of dodecinyl succinic anhydride (Electron
Microscopy Sciences, Fort Washington, PA) propylene oxide and
hardened at 601C. Thin sections (1 mm or less) were examined with a
JEM-1200 EX electron microscope (JEOL,Tokyo, Japan).
Flow cytometry Isolated LC and dermal DC were analyzed for cell
surface expression of various proteins by FACSORT £ow cytometer
(Becton Dickinson,Tokyo, Japan) as described previously (Pen a-Cruz et al,
2001). Mouse monoclonal antibodies used in this study were the 10H3 anti-
CD1a, the L243 anti-MHC class II (American Type Culture Collection),
and anti-CD83 (Immunotech, Marseille, France) antibodies.
RESULTS
CD1a-mediated lipid antigen presentation by freshly isolated
LC To examine directly whether LC might be able to mediate
CD1a-dependent lipid antigen presentation, freshly isolated
LC (fLC) were tested for their ability to present a microbial
lipid antigen to CD1a-restricted, antigen-speci¢c T cells. LC
were isolated from human epidermal cell suspension by
a discontinuous density gradient centrifugation. The cell
population thus obtained comprised about 90% of CD1aþ
immature DC that also expressed LC marker proteins, including
Langerin (Pen a-Cruz et al, 2001). In order to detect CD1a-
mediated antigen presentation by these fLC, we used TCR-
de¢cient Jurkat cells (J.RT3) reconstituted by transfection with
the speci¢c TCR a and b chains derived from a microbial lipid-
antigen-speci¢c, CD1a-restricted Tcell line (CD8-2) (Sugita et al,
1999). As reconstitution of the pair of TCR a and b chains was
su⁄cient to transfer both antigen speci¢city and CD1a restriction,
these TCR-transfected J.RT3 cells (CD8-2/J.RT3) were useful to
examine if fLC might mediate CD1a-restricted lipid antigen
presentation. The CD8-2/J.RT3 cells failed to produce IL-2
when cultured either alone or with fLC in the absence of
speci¢c antigen (Fig 1, labeled as ‘‘no fLC, no Ag’’ and ‘‘þ fLC,
no Ag’’, respectively). In contrast, signi¢cant IL-2 production by
these T cells was observed when they were cultured with fLC in
the presence of speci¢c microbial antigen (labeled as ‘‘þ fLC þ
Ag’’), suggesting an ability of fLC to mediate presentation of
lipid antigen to T cells. This antigen-speci¢c response was
completely blocked by anti-CD1a antibody, but not by a
nonbinding antibody (‘‘neg. cont. Ab’’) and anti-MHC class I
antibody, indicating that CD1a was the restriction element for
the lipid-antigen-speci¢c response. Thus, we concluded that fLC
were capable of mediating CD1a-dependent lipid antigen
presentation toT cells.
Di¡erential ability of fresh and migrating LC and dermal
DC to mediate CD1a-dependent antigen presentation The
human skin contains DC both in the epidermis and in the
dermis, referred to as epidermal LC and dermal DC,
respectively. Di¡erential expression of CD1a molecules in these
two types of skin DC has been noted previously in several
laboratories (Caux et al, 1992), including ours (Pen a-Cruz et al,
2001), but their ability to mediate CD1a-dependent lipid antigen
presentation has not been evaluated. Therefore, we isolated
dermal DC as well as epidermal LC from human skin, and
tested for their ability to present a microbial lipid antigen to the
CD8-2/J.RT3 cells. Following removal of the epidermal sheet for
extraction of LC, DC were isolated from the underlying dermis.
As expected, whereas Birbeck granules were readily detected in
fLC under electron microscope (Fig 2, left), these dermal DC
lacked the LC-speci¢c cytoplasmic structure (Fig 2, middle).
Flow cytometric studies of these two cell types revealed that, in
contrast to fLC that expressed high levels of CD1a molecules on
the cell surface, dermal DC expressed signi¢cantly lower levels
of CD1a molecules and higher levels of MHC class II than fLC
(Fig 3, top panels for fLC and middle panels for dermal DC),
predicting a much more e⁄cient presentation of CD1a-restricted
Figure1. CD1a-dependent presentation of lipid antigens by freshly
isolated LC. J.RT3/LDN5 cells were incubated with fLC in either the pre-
sence or absence of the H37Ra-derived lipid antigens (Ag), and the amount
of IL-2 released into the culture medium was measured. Some cultures
were performed in the presence of negative control antibodies (P3) or anti-
bodies to either CD1a (10H3) or MHC class I (W6/32). Representative re-
sults in three independent experiments are shown.
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lipid antigens by fLC than by dermal DC. Indeed, we found that,
whereas the CD8-2/J.RT3 cells produced a large amount of IL-2
in the presence of fLC even at the lowest concentration of speci¢c
antigen tested, they failed to produce comparable levels of IL-2 in
the presence of dermal DC and only a small amount of IL-2 was
produced at the highest concentration of the antigen (Fig 4).
These results underscored a potentially predominant role of fLC
in CD1a-mediated skin immunity over dermal DC.
CD1a-dependent lipid antigen presentation by migrating
LC One of the salient features of epidermal LC is their ability
to emigrate from the epidermis. It has been proposed that,
following uptake of protein antigens, LC exit the epidermis and
migrate into draining lymph nodes, where they play a crucial role
in stimulating MHC-restricted protein-antigen-speci¢c T cells.
Given the ability of fLC to mediate CD1a-dependent lipid
antigen presentation demonstrated above, we carried out the
subsequent two sets of experiments to analyze LC that had
migrated from the epidermis for their capability of presenting
CD1a-restricted lipid antigens to T cells. To isolate LC migrating
from the epidermis, human skin was digested with dispase and
the epidermis was separated mechanically without any attached
dermal components. The epidermal sheets were then incubated
in culture medium at 371C, and after 2 d cells that had
emigrated from the epidermis during the culture period were
collected. Subsequently, LC-derived cells were further enriched
by a discontinuous density gradient centrifugation as used for
isolation of fLC. Consistent with their being derived from
epidermal LC, the migrating LC (mlC) thus isolated contained
Birbeck granules (Fig 2, right) and expressed CD1a molecules on
the cell surface as abundantly as fLC (Fig 3, top panels for fLC and
bottom panels for mlC). In contrast to fLC, however, which
expressed only moderate levels of MHC class II on the cell
surface, higher levels of MHC class II expression were observed
for mlC, comparable to those for dermal DC (Fig 3). Further,
unlike fLC, which expressed virtually no CD83 molecules, their
upregulated surface expression was detected for mlC, indicating
that mlC underwent signi¢cant maturation. Despite these
phenotypic di¡erences between mlC and fLC, we observed that
mlC were as e⁄cient as fLC in their ability to present a microbial
lipid antigen to CD8-2/J.RT3 cells (Fig 5A).
To extend this observation further, we performed another
experiment in a setting that mimicked physiologic conditions.
In this experiment, the epidermal sheets obtained from human
skin were either pulsed with the microbial antigen or mock-
pulsed, and then migrating LC were isolated and examined for
whether they might express antigen-loaded CD1a molecules and
stimulate antigen-speci¢c, CD1a-restricted T cells. Whereas mlC
migrating from the lipid-antigen-unpulsed epidermis did not
activate CD8-2/J.RT3 cells, those from the lipid-antigen-pulsed
epidermis were capable of activating CD8-2/J.RT3 cells to
produce IL-2 (Fig 5B). Thus, antigen-loaded LC emigrated
from the epidermis that had been pulsed with antigen.
DISCUSSION
We previously showed, using monocyte-derived DC, that CD1a
and CD1b isoforms of the human CD1 family mediate separate
pathways for antigen presentation.Whereas CD1b molecules are
expressed in lysosomes and sample lipid antigens in a vesicular
acidi¢cation dependent manner, CD1a molecules accumulate in
recycling endosomes of the early endocytic system and do not
require vesicular acidi¢cation to function. Unlike most DC sub-
sets, including dermal DC, that express both CD1a and CD1b
molecules, LC are unique in that they virtually lack CD1b ex-
pression but express an abundance of CD1a molecules. Further,
CD1a molecules are prominently expressed intracellularly in Bir-
beck granules, LC-speci¢c cytoplasmic vesicles that are proposed
to represent the early endocytic compartment (McDermott et al,
2002). These observations led us to the hypothesis that LC might
have evolved to e⁄ciently present CD1a-restricted lipid antigens
Figure 2. Electron micrographs of epidermal LC and dermal DC. fLC (left panel) as well as dermal DC (dDC, middle panel) and mlC (right panel) were
observed by transmission electron microscopy. Each small box in the panels for fLC and mlC contains some typical Birbeck granules, and their magni¢ed
views are provided in the insets of the corresponding panels. Scale bar: 200 nm.
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toT cells. Indeed, this study demonstrated that fLC as well as LC
emigrating from the epidermis were e⁄cient in presenting mi-
crobial lipid antigens to speci¢c CD1a-restricted T cells. In con-
trast, dermal DC expressed several-fold less CD1a molecules and
were ine⁄cient in CD1a antigen presentation. These results
demonstrate an outstanding ability of LC to mediate CD1a-
dependent pathways for lipid antigen presentation.
Once activated by in£ammatory stimuli, LC exit the epidermis
and migrate into the T cell area of draining lymph nodes, where
they interact with and activate peptide-antigen-speci¢c T cells.
While tra⁄cking to the lymph nodes, LC undergo drastic cellu-
lar changes, collectively referred to as DC maturation, that in-
clude upregulation of cell surface expression of MHC class II
molecules and T cell costimulatory molecules, such as CD80 and
CD86 (Teunissen, 1992; Banchereau and Steinman, 1998). As a re-
sult, LC exhibit an excellent ability to stimulate MHC class II
restricted na|«ve T cells in lymph nodes. In contrast, CD1a surface
expression is downregulated during the maturation process (Cao
et al, 2002). Further, unlike MHC class II mediated peptide anti-
gen presentation that depends heavily on DC maturation, CD1-
Figure 3. Flow cytometric analysis of LC and dermal DC. fLC (top panels) as well as dermal DC (dDC, middle panels) and mlC (bottom panels) were
tested for their surface expression of MHC class II, CD1a, and CD83 molecules.
Figure 4. fLC, but not dermal DC, were e⁄cient in mediating
CD1a-dependent presentation of microbial lipid antigens to Tcells.
J.RT3/LDN5 cells were incubated with either fLC or dermal DC (dDC) in
the presence of indicated concentrations of the H37Ra-derived lipid
antigens, and the amount of IL-2 released into the culture medium was
measured. Representative results in three independent experiments are
shown.
Figure 5. mlC were e⁄cient in CD1a antigen presentation. (A)
J.RT3/CD8-2 cells were incubated with fLC, dermal DC (dDC), or mlC
in either the presence (¢lled bars) or absence (cross-hatched bars) of the
H37Ra-derived lipid antigens, and the amount of IL-2 released into the
culture medium was measured. (B) Freshly obtained epidermal sheets were
either pulsed with the H37Ra-derived lipid antigens or unpulsed. Subse-
quently, mlC were isolated and tested for their ability to stimulate J.RT3/
CD8-2 cells to produce IL-2.
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mediated lipid antigen presentation occurs e⁄ciently even in im-
mature stages of DC (Cao et al, 2002). Thus, CD1a molecules ex-
pressed on epidermal LC may potentially function to present lipid
antigens locally even before the cells undergo full maturation for
maximum activation of MHC-restricted T cells in lymph nodes.
Antigen-speci¢c T cell immunity has been implicated in var-
ious skin disorders, but previously much attention has been direc-
ted only to the MHC-dependent presentation of peptide antigens
(Smith Pease et al, 2002; Staquet et al, 2002). The MHC-indepen-
dent pathway for lipid antigen presentation by LC, demonstrated
in this study, raised an interesting possibility that the skin immu-
nity might involve T cell recognition of both peptide and lipid
antigens. The epidermis always contacts lipid antigens, such as
those derived from microbes and endogenously synthesized cera-
mides that are known to ¢t into the deep hydrophobic antigen-
binding groove of CD1molecules (Kawano et al, 1997). Exposure
of LC to these lipid antigens particularly in abraded skin may
trigger T-cell-dependent in£ammatory reactions. In addition, it
should be noted that most substances that are responsible for
allergic contact dermatitis are nonprotein compounds (Gorba-
chev and Fairchild, 2001; Staquet et al, 2002). Some of them, in-
cluding primin and pentadesyl catechol derived from certain
plants, contain long alkyl chains that may interact with the CD1
hydrophobic groove. Local activation of T cells seen in contact
dermatitis may involve LC-mediated activation of CD1a-re-
stricted T cells. This study sheds light on a new aspect of T cell
immunity in the skin.
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